# Enliven Therapeutics, Inc.: Form SC 13D/A, filed May 20, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: SC 13D/A
- Filed: 2024-05-20
- Accepted by EDGAR: May 20, 2024, 16:55 ET
- Period: not reported
- Accession: 0000947871-24-000499
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000094787124000499/ss3408593_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000094787124000499/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000094787124000499/ss3408593_sc13da.htm

Filed May 20, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000499. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.
